rosiglitazone has been researched along with nitrates in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batinic-Haberle, I; Christopher, TA; Gao, E; Liu, HR; Lopez, BL; Ma, XL; Ohlstein, EH; Tao, L; Teng, ZP; Willette, RN; Yue, TL | 1 |
| Caputi, AP; Chatterjee, PK; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Genovese, T; Ialenti, A; Ianaro, A; Maffia, P; Patel, NS; Pisano, B; Thiemermann, C | 1 |
| Boscá, L; Cárdenas, A; Castillo, J; Dávalos, A; Hurtado, O; Lizasoain, I; Lorenzo, P; Moro, MA; Pereira, MP; Serena, J; Vivancos, J | 1 |
| Hu, CP; Jiang, JL; Li, YJ; Wang, S; Yang, DL; Zhang, XJ | 1 |
| Jones, AV; Lamarca, BB; Racusen, LC; Reckelhoff, JF; Romero, DG; Ryan, MJ; Sartori-Valinotti, JC; Venegas-Pont, MR; Yanes, LL | 1 |
| Balakumar, P; Goel, RK; Kaur, T | 1 |
| Coleman, J; Fenrick, B; Gleason, PP; Starner, CI; Wickersham, P | 1 |
7 other study(ies) available for rosiglitazone and nitrates
| Article | Year |
|---|---|
Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia.
Topics: Animals; Antioxidants; Blood Vessels; Carotid Arteries; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Hypercholesterolemia; In Vitro Techniques; Lipids; Male; Nitrates; Nitric Oxide; Nitrites; Rabbits; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors; Tyrosine; Vasodilation | 2003 |
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cyclooxygenase 2; Cytokines; Dinoprostone; Edema; Exudates and Transudates; Immunohistochemistry; Isoenzymes; Lipid Peroxidation; Lung; Male; Neutrophil Infiltration; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Peroxidase; Pleurisy; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tyrosine | 2004 |
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Disease Models, Animal; Drug Administration Schedule; Electrophoresis, Gel, Two-Dimensional; Gene Expression Regulation, Enzymologic; I-kappa B Proteins; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; NF-kappa B; NF-KappaB Inhibitor alpha; Nitrates; Nitric Oxide Synthase Type II; Nitrites; Oligonucleotide Array Sequence Analysis; PPAR gamma; Prostaglandin D2; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Time Factors | 2006 |
Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells.
Topics: Acetylcholine; Animals; Aorta; Arginine; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Male; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide Synthase; Nitrites; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Vasodilation | 2007 |
Rosiglitazone reduces blood pressure in female Dahl salt-sensitive rats.
Topics: Albuminuria; Animals; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Chemokine CCL2; Cholesterol; Estradiol; Feeding Behavior; Female; Gene Expression Regulation; Immunohistochemistry; Inflammation; Insulin; Kidney; Leptin; Nitrates; Nitrites; Osteopontin; Ovariectomy; Rats; Rats, Inbred Dahl; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2010 |
Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
Topics: Animals; Aorta, Thoracic; Arsenites; Blood Glucose; Endothelium, Vascular; Glutathione; In Vitro Techniques; Male; Nitrates; Nitric Oxide; Nitrites; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Rosiglitazone; Sodium Compounds; Thiazolidinediones; Thiobarbituric Acid Reactive Substances; Vasodilation; Water Pollutants, Chemical | 2010 |
Rosiglitazone prior authorization safety policy: a cohort study.
Topics: Blue Cross Blue Shield Insurance Plans; Cohort Studies; Contraindications; Diabetes Mellitus, Type 2; Drug Utilization Review; Female; Humans; Hypoglycemic Agents; Insulin; Insurance, Health, Reimbursement; Male; Middle Aged; Nitrates; Rosiglitazone; Thiazolidinediones | 2012 |